Michaela Jeong

1.1k total citations · 4 hit papers
11 papers, 816 citations indexed

About

Michaela Jeong is a scholar working on Molecular Biology, Animal Science and Zoology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michaela Jeong has authored 11 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Animal Science and Zoology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michaela Jeong's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Animal Virus Infections Studies (3 papers). Michaela Jeong is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Animal Virus Infections Studies (3 papers). Michaela Jeong collaborates with scholars based in South Korea and United States. Michaela Jeong's co-authors include Hyukjin Lee, Yeji Lee, Hyein Jung, M. Kim, K. Lee, Jiyoung Park, Y. Cho, Hye Ri Jung, Ki Taek Nam and Sun Jin Hur and has published in prestigious journals such as Advanced Functional Materials, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Michaela Jeong

11 papers receiving 798 citations

Hit Papers

Engineered ionizable lipid nanoparticles for targeted del... 2021 2026 2022 2024 2021 2023 2022 2023 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver
    2021 282 citations M. Kim, Michaela Jeong et al. Science Advances profile →
  2. Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
    2023 205 citations Yeji Lee, Michaela Jeong et al. Experimental & Molecular Medicine profile →
  3. In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
    2022 130 citations M. Kim, Michaela Jeong et al. Science Advances profile →
  4. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
    2023 125 citations Michaela Jeong, Yeji Lee et al. Advanced Drug Delivery Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Jeong South Korea 8 656 121 115 88 80 11 816
Elisa Schrader Echeverri United States 10 560 0.9× 96 0.8× 79 0.7× 81 0.9× 86 1.1× 20 738
Jerry Leung Canada 13 837 1.3× 153 1.3× 115 1.0× 127 1.4× 104 1.3× 23 1.1k
Marine Z. C. Hatit United States 16 924 1.4× 142 1.2× 123 1.1× 120 1.4× 132 1.6× 17 1.2k
Kepan Chen China 8 619 0.9× 180 1.5× 105 0.9× 46 0.5× 122 1.5× 10 804
Nuphar Veiga Israel 9 851 1.3× 163 1.3× 202 1.8× 144 1.6× 78 1.0× 10 1.0k
Niels Dammes Israel 9 859 1.3× 186 1.5× 178 1.5× 92 1.0× 118 1.5× 10 1.1k
Antony Jozić United States 13 939 1.4× 138 1.1× 142 1.2× 99 1.1× 141 1.8× 21 1.1k
Sushmita Chatterjee Israel 13 623 0.9× 153 1.3× 88 0.8× 131 1.5× 43 0.5× 18 847
Kota Tange Japan 19 615 0.9× 215 1.8× 145 1.3× 115 1.3× 96 1.2× 30 828
Xuewei Zhao United States 12 854 1.3× 169 1.4× 161 1.4× 79 0.9× 66 0.8× 12 1.0k

Countries citing papers authored by Michaela Jeong

Since Specialization
Citations

This map shows the geographic impact of Michaela Jeong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Jeong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Jeong more than expected).

Fields of papers citing papers by Michaela Jeong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Jeong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Jeong. The network helps show where Michaela Jeong may publish in the future.

Co-authorship network of co-authors of Michaela Jeong

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Jeong. A scholar is included among the top collaborators of Michaela Jeong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Jeong. Michaela Jeong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lee, Yeji, et al.. (2025). Development of lipid nanoparticle formulation for intramuscular administration of mRNA vaccine against respiratory syncytial virus. Journal of Pharmaceutical Investigation. 55(5). 735–747. 1 indexed citations
2.
Jin, Hee Kyung, So‐Yeon Park, Ji‐Eun Lee, et al.. (2024). GTSE1-driven ZEB1 stabilization promotes pulmonary fibrosis through the epithelial-to-mesenchymal transition. Molecular Therapy. 32(11). 4138–4157. 7 indexed citations
3.
Jeong, Michaela, Sumin Shin, Yeji Lee, et al.. (2024). Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis. Journal of Controlled Release. 374. 337–348. 6 indexed citations
4.
Lee, Yeji, et al.. (2024). Development of Lipid Nanoparticle Formulation for the Repeated Administration of mRNA Therapeutics. Biomaterials Research. 28. 17–17. 13 indexed citations
5.
Jeong, Michaela, et al.. (2023). Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications. Advanced Drug Delivery Reviews. 200. 114990–114990. 125 indexed citations breakdown →
6.
Lee, Yeji, et al.. (2023). Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. Experimental & Molecular Medicine. 55(10). 2085–2096. 205 indexed citations breakdown →
7.
Kim, Minjeong, Michaela Jeong, Yeji Lee, et al.. (2023). Novel piperazine‐based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety. Bioengineering & Translational Medicine. 8(6). e10556–e10556. 18 indexed citations
8.
Kim, M., Michaela Jeong, Yeji Lee, et al.. (2022). In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy. Science Advances. 8(3). eabj6901–eabj6901. 130 indexed citations breakdown →
9.
Jin, Hee Kyung, Michaela Jeong, Minjeong Kim, et al.. (2022). Engineered Lipid Nanoparticles for the Treatment of Pulmonary Fibrosis by Regulating Epithelial‐Mesenchymal Transition in the Lungs. Advanced Functional Materials. 33(7). 26 indexed citations
10.
Jang, Bora, Hye-Jin Jang, Hyunsook Kim, et al.. (2021). Protein-RNA interaction guided chemical modification of Dicer substrate RNA nanostructures for superior in vivo gene silencing. Journal of Controlled Release. 343. 57–65. 3 indexed citations
11.
Kim, M., Michaela Jeong, Sun Jin Hur, et al.. (2021). Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Science Advances. 7(9). 282 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Schrader Echeverri Breakdown of academic impact, for papers by Jerry Leung Breakdown of academic impact, for papers by Marine Z. C. Hatit Breakdown of academic impact, for papers by Kepan Chen Breakdown of academic impact, for papers by Nuphar Veiga Breakdown of academic impact, for papers by Niels Dammes Breakdown of academic impact, for papers by Antony Jozić Breakdown of academic impact, for papers by Sushmita Chatterjee Breakdown of academic impact, for papers by Kota Tange Breakdown of academic impact, for papers by Xuewei Zhao
Rankless by CCL
2026